APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral COVID-19 Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral COVID-19 Vaccine Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchOral COVID-19 Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral COVID-19 Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Oral COVID-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral COVID-19 Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral COVID-19 Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral COVID-19 Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral COVID-19 Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral COVID-19 Vaccine market include Shandong Xinhua Pharmaceutical, CanSino Biologics, Kintor Pharmaceutical, Pfizer, Zhejiang Huahai Pharmaceutical Co.,ltd., Henan Genuine Biotech Co., Ltd. and Kindred Biosciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral COVID-19 Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral COVID-19 Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral COVID-19 Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral COVID-19 Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral COVID-19 Vaccine Segment by Company

Shandong Xinhua Pharmaceutical

CanSino Biologics

Kintor Pharmaceutical

Pfizer

Zhejiang Huahai Pharmaceutical Co.,ltd.

Henan Genuine Biotech Co., Ltd.

Kindred Biosciences, Inc.

Oral COVID-19 Vaccine Segment by Type

Tablet Type

Inhalable Type

Oral COVID-19 Vaccine Segment by Application

Adults

Children

Elderly

Oral COVID-19 Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oral COVID-19 Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral COVID-19 Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral COVID-19 Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Oral COVID-19 Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral COVID-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral COVID-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral COVID-19 Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral COVID-19 Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral COVID-19 Vaccine industry.

Chapter 3: Detailed analysis of Oral COVID-19 Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral COVID-19 Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral COVID-19 Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral COVID-19 Vaccine Industry Trends Table 2. Oral COVID-19 Vaccine Industry Drivers Table 3. Oral COVID-19 Vaccine Industry Opportunities and Challenges Table 4. Oral COVID-19 Vaccine Industry Restraints Table 5. Global Oral COVID-19 Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral COVID-19 Vaccine Revenue Share by Company (2021-2026) Table 7. Global Oral COVID-19 Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Oral COVID-19 Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Oral COVID-19 Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Oral COVID-19 Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral COVID-19 Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Oral COVID-19 Vaccine Company, Product Type & Application Table 13. Global Oral COVID-19 Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Type Table 18. Significant Companies of Inhalable Type Table 19. Global Oral COVID-19 Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Oral COVID-19 Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Oral COVID-19 Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Oral COVID-19 Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Oral COVID-19 Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Oral COVID-19 Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oral COVID-19 Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Oral COVID-19 Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Oral COVID-19 Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Oral COVID-19 Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adults Table 30. Significant Companies of Children Table 31. Significant Companies of Elderly Table 32. Global Oral COVID-19 Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Oral COVID-19 Vaccine Sales Volume by Application (2021-2026) & (k units) Table 34. Global Oral COVID-19 Vaccine Sales Volume by Application (2027-2032) & (k units) Table 35. Global Oral COVID-19 Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Oral COVID-19 Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Oral COVID-19 Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Oral COVID-19 Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Oral COVID-19 Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Oral COVID-19 Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Oral COVID-19 Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Oral COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Oral COVID-19 Vaccine Sales by Region (2021-2026) & (k units) Table 44. Global Oral COVID-19 Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Oral COVID-19 Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Oral COVID-19 Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Oral COVID-19 Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Oral COVID-19 Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Oral COVID-19 Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Oral COVID-19 Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Oral COVID-19 Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Oral COVID-19 Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Oral COVID-19 Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Oral COVID-19 Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Oral COVID-19 Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 57. Global Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Oral COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 59. Global Oral COVID-19 Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Oral COVID-19 Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Oral COVID-19 Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Oral COVID-19 Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Oral COVID-19 Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Shandong Xinhua Pharmaceutical Company Information Table 65. Shandong Xinhua Pharmaceutical Business Overview Table 66. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio Table 68. Shandong Xinhua Pharmaceutical Recent Development Table 69. CanSino Biologics Company Information Table 70. CanSino Biologics Business Overview Table 71. CanSino Biologics Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. CanSino Biologics Oral COVID-19 Vaccine Product Portfolio Table 73. CanSino Biologics Recent Development Table 74. Kintor Pharmaceutical Company Information Table 75. Kintor Pharmaceutical Business Overview Table 76. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio Table 78. Kintor Pharmaceutical Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Pfizer Oral COVID-19 Vaccine Product Portfolio Table 83. Pfizer Recent Development Table 84. Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information Table 85. Zhejiang Huahai Pharmaceutical Co.,ltd. Business Overview Table 86. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio Table 88. Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Development Table 89. Henan Genuine Biotech Co., Ltd. Company Information Table 90. Henan Genuine Biotech Co., Ltd. Business Overview Table 91. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio Table 93. Henan Genuine Biotech Co., Ltd. Recent Development Table 94. Kindred Biosciences, Inc. Company Information Table 95. Kindred Biosciences, Inc. Business Overview Table 96. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio Table 98. Kindred Biosciences, Inc. Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Oral COVID-19 Vaccine Distributors List Table 102. Oral COVID-19 Vaccine Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Oral COVID-19 Vaccine Product Image Figure 2. Global Oral COVID-19 Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral COVID-19 Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral COVID-19 Vaccine Sales (2021-2032) & (k units) Figure 5. Global Oral COVID-19 Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Oral COVID-19 Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Type Image Figure 10. Inhalable Type Image Figure 11. Global Oral COVID-19 Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Oral COVID-19 Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Oral COVID-19 Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Oral COVID-19 Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oral COVID-19 Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oral COVID-19 Vaccine Sales Value Share by Type (2021-2032) Figure 17. Adults Image Figure 18. Children Image Figure 19. Elderly Image Figure 20. Global Oral COVID-19 Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Oral COVID-19 Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Oral COVID-19 Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Oral COVID-19 Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Oral COVID-19 Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Oral COVID-19 Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Oral COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Oral COVID-19 Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Oral COVID-19 Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Oral COVID-19 Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Oral COVID-19 Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Oral COVID-19 Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Oral COVID-19 Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Oral COVID-19 Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Oral COVID-19 Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Oral COVID-19 Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Oral COVID-19 Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Oral COVID-19 Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Oral COVID-19 Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Oral COVID-19 Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Oral COVID-19 Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Oral COVID-19 Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet Type
  • Inhalable Type
Applications
  • Adults
  • Children
  • Elderly
Companies covered
  • Shandong Xinhua Pharmaceutical
  • CanSino Biologics
  • Kintor Pharmaceutical
  • Pfizer
  • Zhejiang Huahai Pharmaceutical Co.,ltd.
  • Henan Genuine Biotech Co., Ltd.
  • Kindred Biosciences, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral COVID-19 Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Oral COVID-19 Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Oral COVID-19 Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral COVID-19 Vaccine Market Dynamics
  1. 2.1 Oral COVID-19 Vaccine Industry Trends
  2. 2.2 Oral COVID-19 Vaccine Industry Drivers
  3. 2.3 Oral COVID-19 Vaccine Industry Opportunities and Challenges
  4. 2.4 Oral COVID-19 Vaccine Industry Restraints
3 Oral COVID-19 Vaccine Market by Company
  1. 3.1 Global Oral COVID-19 Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Oral COVID-19 Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Oral COVID-19 Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral COVID-19 Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Oral COVID-19 Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Oral COVID-19 Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral COVID-19 Vaccine Company Product Type and Application
  8. 3.8 Global Oral COVID-19 Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral COVID-19 Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral COVID-19 Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral COVID-19 Vaccine Market by Type
  1. 4.1 Oral COVID-19 Vaccine Type Introduction
  2. 4.1.1 Tablet Type
  3. 4.1.2 Inhalable Type
  4. 4.2 Global Oral COVID-19 Vaccine Sales Volume by Type
  5. 4.2.1 Global Oral COVID-19 Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral COVID-19 Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Oral COVID-19 Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Oral COVID-19 Vaccine Sales Value by Type
  9. 4.3.1 Global Oral COVID-19 Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral COVID-19 Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Oral COVID-19 Vaccine Sales Value Share by Type (2021-2032)
5 Oral COVID-19 Vaccine Market by Application
  1. 5.1 Oral COVID-19 Vaccine Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.1.3 Elderly
  5. 5.2 Global Oral COVID-19 Vaccine Sales Volume by Application
  6. 5.2.1 Global Oral COVID-19 Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral COVID-19 Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Oral COVID-19 Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Oral COVID-19 Vaccine Sales Value by Application
  10. 5.3.1 Global Oral COVID-19 Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oral COVID-19 Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Oral COVID-19 Vaccine Sales Value Share by Application (2021-2032)
6 Oral COVID-19 Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Oral COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral COVID-19 Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Oral COVID-19 Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Oral COVID-19 Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Oral COVID-19 Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral COVID-19 Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral COVID-19 Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral COVID-19 Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Oral COVID-19 Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral COVID-19 Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Oral COVID-19 Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral COVID-19 Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Oral COVID-19 Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral COVID-19 Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral COVID-19 Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral COVID-19 Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Oral COVID-19 Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral COVID-19 Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral COVID-19 Vaccine Sales Value Share by Country, 2025 VS 2032
7 Oral COVID-19 Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Oral COVID-19 Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral COVID-19 Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral COVID-19 Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Oral COVID-19 Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Oral COVID-19 Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Oral COVID-19 Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral COVID-19 Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral COVID-19 Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral COVID-19 Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral COVID-19 Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral COVID-19 Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Xinhua Pharmaceutical
  2. 8.1.1 Shandong Xinhua Pharmaceutical Company Information
  3. 8.1.2 Shandong Xinhua Pharmaceutical Business Overview
  4. 8.1.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
  6. 8.1.5 Shandong Xinhua Pharmaceutical Recent Developments
  7. 8.2 CanSino Biologics
  8. 8.2.1 CanSino Biologics Company Information
  9. 8.2.2 CanSino Biologics Business Overview
  10. 8.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CanSino Biologics Oral COVID-19 Vaccine Product Portfolio
  12. 8.2.5 CanSino Biologics Recent Developments
  13. 8.3 Kintor Pharmaceutical
  14. 8.3.1 Kintor Pharmaceutical Company Information
  15. 8.3.2 Kintor Pharmaceutical Business Overview
  16. 8.3.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
  18. 8.3.5 Kintor Pharmaceutical Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Oral COVID-19 Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Oral COVID-19 Vaccine Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Zhejiang Huahai Pharmaceutical Co.,ltd.
  26. 8.5.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
  27. 8.5.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Business Overview
  28. 8.5.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio
  30. 8.5.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments
  31. 8.6 Henan Genuine Biotech Co., Ltd.
  32. 8.6.1 Henan Genuine Biotech Co., Ltd. Company Information
  33. 8.6.2 Henan Genuine Biotech Co., Ltd. Business Overview
  34. 8.6.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio
  36. 8.6.5 Henan Genuine Biotech Co., Ltd. Recent Developments
  37. 8.7 Kindred Biosciences, Inc.
  38. 8.7.1 Kindred Biosciences, Inc. Company Information
  39. 8.7.2 Kindred Biosciences, Inc. Business Overview
  40. 8.7.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio
  42. 8.7.5 Kindred Biosciences, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral COVID-19 Vaccine Value Chain Analysis
  2. 9.1.1 Oral COVID-19 Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral COVID-19 Vaccine Sales Mode & Process
  6. 9.2 Oral COVID-19 Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral COVID-19 Vaccine Distributors
  9. 9.2.3 Oral COVID-19 Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst